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The death of serum-deprived undifferentiated PC12 cells
shows both autophagic and apoptotic features. Since it is
still controversial whether the autophagy is instrumental
in the cell death or a mere epiphenomenon, we tested the
effects of inhibiting the autophagy by a variety of phos-
phoinositide 3-kinase inhibitors, and provided evidence
that the autophagy, or a related trafficking event, is indeed
instrumental in the cell death. Furthermore, by compar-
ing the effects of PI3-K inhibition and caspase-inhibition
on autophagic and apoptotic cellular events, we showed
that in this case the autophagic and apoptotic mecha-
nisms mediate cell death by parallel pathways and do not
act in series.
Keywords: apoptosis; autophagic cell death; LY294002; PI3-
kinases.
Introduction
Autophagy is the mechanism by which cells degrade their
own cytoplasmic content using the lysosomal machinery.
There are several forms of it, including microautophagy,
the direct capture of tiny portions of cytosol by invagina-
tion of lysosomal membranes, and macroautophagy, which
involves the engulfment of sizeable regions of cytoplasm,
including organelles, by phagosomes (derived from the
endoplasmic reticulum and perhaps other sources such as
the trans-Golgi network)1 followed by their fusion with
lysosomes. These (and other) forms of autophagy are in-
volved in the normal turnover of cell contents and are
enhanced by cellular stresses, against which they provide
protection, e.g. by replenishing the pool of free amino
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acids in the case of amino acid depletion,2,3 or by elimi-
nating damaged proteins.4
Despite the life-promoting roles of autophagy,
macroautophagy has also been associated with cell death,
and the term autophagic cell death is used as a classifica-
tion for dying cells undergoing intense macroautophagy.5
This type of cell death occurs frequently during em-
bryonic development and is probably the most com-
mon type of cell death in insect metamorphosis,5 but
(macro)autophagic features are also associated with many
cases of pathological cell death including heart failure,6
excitotoxicity7 and neurodegenerative diseases including
Alzheimer’s disease.8 In its pure form, autophagic cell
death is caspase-independent and is clearly distinct from
canonical apoptosis,6,9–11, although mixed forms can oc-
cur that show both autophagic and caspase-related apop-
totic features.12–16
While the existence of autophagic cell death as a dis-
tinct morphological type is beyond dispute, the question
of whether the autophagy is instrumental for the cell death
is still not entirely resolved (see Discussion). The fact that
3-methyladenine (3-MA), which prevents the formation
of autophagic vacuoles, inhibits both the pure autophagic
cell death and the mixed form in numerous situations ar-
gues in favour of an instrumental role,12,15 but since the
specificity and mode of action of 3-MA are unclear, more
evidence is needed.
Since one effect of 3-MA is to inhibit phosphoinositide
3-kinases (PI3-K), and since better characterized specific
inhibitors of PI3-K are available and are known to in-
hibit autophagy2,3 we here test the effects of the PI3-K
inhibitors LY294002 (and, in pilot experiments, wort-
mannin) as well as 3-MA, on serum-deprived PC12 cells,
whose cell death is known to have autophagic as well
as apoptotic features.13,14,17 We show that these com-
pounds inhibit (macro)autophagy and protect against the
cell death, suggesting that autophagy does indeed play
a causal role in it, although we also provide evidence for
a caspase-3 related apoptotic mechanism acting probably
in parallel.
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Materials and methods
Cell cultures and pharmacological inhibitors
PC12 cells were cultured in Dulbecco’s Modified Eagle’s
Medium (DMEM, Life Technologies) containing a high
level of glucose (4,5 g/L) supplemented with 10% heat-
inactivated foetal calf serum (Amimed). Before starvation,
cells were washed four times in serum-free DMEM by
centrifugation and plated at 1× 106 cells/well in six-well
plates. In each experiment, cells were cultured in the pres-
ence of serum (as controls), or without serum, or without
serum but in the presence of variable concentrations of
the following inhibitors: LY294002 (10–100 µM; Sigma)
from a 10 mM stock solution in DMSO; or 3-MA (5–
15 mM; Sigma) from a 500 mM stock solution in ethanol;
or the pan-caspase inhibitor z-VAD.fmk (50–100 µM;
Bachem) from a 100 mM stock solution in ethanol; or, in a
few pilot experiments, wortmannin (10nM-1µM; Sigma)
from a 1 µM stock solution in DMSO. When tested on
control cells, these compounds had no toxic effect at the
concentrations used.
Cytochemistry and immunocytochemistry
Acid phosphatase activity. Cells cultured on poly-L-lysine-
coated glass coverslips under various experimental condi-
tions were washed three times in water prior to fixation in
1% paraformaldehyde: 0.5% glutaraldehyde for 15 min-
utes at room temperature followed by 4 washes in phos-
phate buffered saline (PBS). The cells were then assayed
for acid phosphatase activity using β-glycerophosphate
as substrate with lead nitrate as donor, followed by reve-
lation with ammonium sulphide,18,19 and mounted in a
1:1 PBS:glycerol mounting medium. Cells with clumped
acid phosphatase (AcP) activity (presumably secondary
lysosomes) were then counted (see later for statistics).
Immunocytochemistry was done on cells cultured on cover-
slips and fixed with 3% formaldehyde in PBS containing
3% sucrose. The cells were permeabilised with 0.2% tri-
ton in PBS and incubated in blocking solution (milk) and
finally with the antibodies following published protocols
(ref.20 for the 6C4 monoclonal antibody against lysobi-
phosphatidic acid (LBPA), a gift from Prof. J. Gruenberg;
and ref.21 for polyclonal anti-Vps34, a gift from Prof. T
Yoshimori). The secondary antibody used to detect LBPA
was coupled to FITC and the one to detect Vps34 was
coupled to CY3. The sections were viewed by confocal
microscopy.
Nissl staining. Cells cultured on poly-L-lysine-coated
glass coverslips were washed in PBS, fixed in 4%
paraformaldehyde for 20 minutes at room temperature
and the coverslips immersed in 0.1% cresyl violet for 15
seconds, washed in PBS and mounted in PBS:glycerol
mounting medium.
Electron microscopy
Cells cultured in Petri dishes were washed 4 times in cold
Sorensen’s phosphate buffer, fixed in 2% glutaraldehyde
in the same buffer for 1 hour at 4◦C, washed 3 times for
10 minutes at 4◦C before being scraped and pelleted for
embedding in 1% low melting point agarose to enable
small pieces to be cut; post-fixation was in 2% osmium
tetroxide, followed by dehydration in graded ethanols and
embedding in Epon. Thin sections were cut using an ul-
tramicrotome and contrasted with uranyl acetate and lead
citrate.
Cell counts and cell death assay
Surviving cells (all adherent cells, both healthy and py-
knotic) were counted in Nissl-stained preparations, and
the ratio of pyknotic cells versus normal ones was esti-
mated from the same preparations. In both cases, at least
200 cells were counted for each condition and the one-
tailed unpaired t test was used for statistical evaluation
of the results. In each experiment, control cells are cells
cultured in a serum-containing medium and the percent
survival is the ratio between the total number of cells in
serum free medium and the total number in the control
condition.
Cumulative cell loss was evaluated by measuring lactate
dehydrogenase (LDH) released into the culture medium
with the Cytotox 96 assay kit (Promega). Three exper-
iments were performed, comparing LY294002-treated
serum-deprived cultures with untreated (but serum-
deprived) controls, involving respectively 2, 3 and 5 pairs
of cultures. In each experiment the percent protection was
calculated.
Immunoblotting to reveal caspase-3 activation
Cells cultured in Petri dishes were lysed in tris-buffered
saline (TBS) containing 0,1% Triton-X100 and lysates
kept at−20◦C before clearance of cell debris by centrifu-
gation at 14.000 rpm, at 4◦C, for 10 minutes. Protein
concentration was estimated with the Bradford protocol
and 25 µg of total protein in Laemmli buffer was loaded
on 12% acryl-bisacrylamide gels and subjected to SDS-
PAGE. After transfer on nitrocellulose membranes, the
blots were blocked in TBS/milk, incubated with antibod-
ies against caspase-3 (rabbit IgG, R&D Systems, 1:1000),
or cleaved caspase-3 (rabbit, Cell Signaling, specific for
the large fragment after cleavage at Asp175; 1:5000) or
α-tubulin (monoclonal IgM, Santa Cruz, 1:500). HRP-
coupled secondary antibodies were from Vector Labora-
tories. Detection of the signals was performed using the
Amersham ECL reagent. For quantification of the blots,
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X-ray films exposed to the ECL signals were scanned on
an EpsonExpression 1680 Pro flatbed scanner at 300 dpi
and 16 bit gray levels. Images were stored as TIF files.
Densitometric analysis of the bands corresponding to the
cleaved form of Caspase-3 (17 + 19 kDa) was carried out
using QuantityOne v4.2.3 software (Biorad). Cleaved cas-
pase levels after 24 h serum starvation in the absence of




Autophagy is characterised by the accumulation of cyto-
plasmic vacuoles containing cell debris. To visualize this
phenomenon in the dying PC12 cells, we performed elec-
tron microscopy on control and serum-deprived cells after
Figure 1. Ultrastructural appearance of healthy and dying cells. (a) 3 cells cultured for 16 h in complete medium, with a healthy
morphology; (b) and (c) one cell cultured in serum-free medium for 14 h at two different magnifications. V: empty vacuoles; Av: autophagic
vacuoles. Bars: (a) 2 µm; (b) 1 µm; (c) 0.2 µm.
16 and 24 h of culture. At 16 h we could indeed deter-
mine the presence of empty vacuoles (V) and autophagic
vacuoles (Av) as described by Ohsawa et al.14 in serum-
deprived cells (Figure 1). Already at 16 h of serum-free
culture, some of the cells showed condensed nuclei (as is
seen in apoptosis), but this phenotype was more promi-
nent at 24 h (data not shown).14,17 Thus, the ultrastruc-
ture suggested the activation of autophagic and apoptotic
pathways, and additional necrotic mechanisms cannot be
excluded in view of the empty vacuoles.
Autophagic and apoptotic features of PC12 cells
at different times of serum-free culture
As a straightforward, light microscopic indicator of the
presence of autolysosomes we used acid phosphatase (AcP)
cytochemistry, specific for the lysosomal compartment.
With this method, primary lysosomes, if detected at all,
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appear as minute spots of reaction product, but larger
clumps (>1 µM) indicate the presence of secondary
lysosomes such as those occurring in autophagic cell
death.18,22 Already at 12 h of serum-free culture, there
was an increase in the percentage of cells labelled for the
active enzyme, but the maximal percentage was at 16 h
(Figure 2b). The reaction product was granular, and lo-
calized mainly in the perinuclear region (Figure 2a). As
a marker of late endosomes, an antibody against lyso-
biphosphatidic acid (LBPA)20 was also used and showed
Figure 2. Time-courses of markers of the two kinds of cell death following serum deprivation. (a) AcP reaction in cells cultured for
16 h with (control) or without serum. Arrowheads show secondary lysosomes. Bar, 10 µm; (b) Percentages of cells with AcP-positive
granules as percent of all cells at different times of culture (+/−SD) n = 4, ∗ p < 0.05 compared to control (one-tailed unpaired t-test).
(c) Percentages of pyknotic cells at different times of culture as percent of all cells (+/−SD) 5 ≤ n ≤ 8, ∗ p < 0.05 compared to control
(one-tailed unpaired t-test).
the appearance of granular cytoplasmic labelling mainly
after 12 h of culture without serum whereas no labelling
was detectable in complete medium (data not shown).
These results confirm the accumulation of acidic compart-
ments in the dying PC12 cells, indicating the occurrence
of (macro)autophagy. After 16 h serum deprivation, the
percentage of AcP-positive cells decreased despite the fact
that the number of dying cells increased.
Many of the serum-deprived cells were also shrunken,
with condensed, darkly-stained nuclei (henceforth:
1034 Apoptosis · Vol 10 · No 5 · 2005
Role of phosphoinositide 3-kinase in autophagic cell death
“pyknotic cells”). Although not strictly specific for apop-
tosis, this morphology is a characteristic feature of it. The
proportion of pyknotic cells increased steadily with the
time in serum-free culture, reaching 50% at 24 h (Figure
2c), and caspase-3 was activated in parallel (see below and
Figure 6a, b).
Effects of inhibiting PI3-K or caspases
Acid phosphatase (AcP) histochemistry. Since PI3-K in-
hibitors inhibit autophagy,2 we examined in our model
whether they affect the appearance of acid phosphatase
reactivity. Indeed, the proportion of AcP-positive cells
was reduced by culturing in the presence of the PI3-
K inhibitors LY294002 or 3-MA (Figure 3a). This
observation suggests a role of PI3-K activity in the
formation of the acidic compartments. In contrast,
the acid phosphatase labelling was not affected by
treatment with the pan-caspase inhibitor z-VAD.fmk
(Figure 3a).
Pyknotic cell counts. In parallel to the decrease in AcP-
positive cells, we observed a decrease in pyknosis in the
presence of either LY294002 or z-VAD.fmk (Figure 3b).
Figure 3. Effects of pharmacological inhibitors. (a) Effects on the percentages of AcP-positive cells after 16 h of culture (+/−SD) n = 4.
Mock is serum-deprived in absence of inhibitor. ∗Mock is different from control (p < 10−5); #inhibitor conditions are different from mock
(p < 0.005). (b) Effects on the percentages of pyknotic cells after different times of serum deprivation (+/−SD) 5 ≤ n ≤ 8, ∗ p < 0.05
compared to serum-free. One-tailed unpaired t-test was used in each case.
In pilot experiments, protection similar to that with
LY294002 was seen also with wortmannin (100 nM or
1 µM, but not with 10 nM), but for the main quantita-
tive evaluations LY294002 was preferred because wort-
mannin is unstable and needs to be renewed every few
hours, which is inconvenient in 24 h experiments. Since
cellular pyknosis has frequently been reported to be pre-
vented by caspase inhibitors, its decrease in the pres-
ence of z-VAD.fmk was expected. The effect of the PI3-
K inhibitor is more surprising and suggests the exis-
tence of a link between autophagy and apoptosis in the
cells.
Quantification of cell survival. Since counts of pyknotic
cells indicate the rate of cell death rather than its total
extent,23 we evaluated cell survival by counting the ad-
hering cells after 24 h serum deprivation. A dose-response
trial of LY294002 showed strong protection against cell
death (Figure 4a), the maximal effect being at 50 µM. At
this concentration, the cell loss was reduced from 58% to
17%, a protection of 71%. 10 mM 3-MA, a standard dose
used to inhibit autophagy2,12,15 reduced the cell loss just
over 40%, as did 100 µM z-VAD.fmk (Figure 4b). The
protection with 50 µM LY294002 was confirmed with an
LDH assay, which showed an 85 (±17 SD) % reduction
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Figure 4. Cell survival after 24 h of serum deprivation. (a) Per-
centages of surviving adherent cells relative to the control (serum-
deprived without inhibitor) for different doses of LY294002 (±SD)
4 ≤ n ≤ 13; ∗ p = 0.002; ∗∗ p = 4 × 10−5. (b) Effects of 3-MA
(10 mM), LY294002 (50 µM) and z-VAD.fmk (100 µM) on percent-
ages of surviving adherent cells (±SD) 4 ≤ n ≤ 13, ∗ p = 0.002,
∗∗ p = 8.9× 10−5.
in LDH-release (n = 3, p = 0.007, one-tailed paired
t-test). The protective efficacy of LY294002 and 3-MA
suggests that inhibiting the formation of autophagic vac-
uoles protects against cell death in this model and indi-
cates that PI3-K plays a role in this cell death process, in
accordance with previous results on other cell lines and
death stimuli.12,15
VPS34 immunocytochemistry
Since the protective effects of the PI3-K inhibitors would
be most easily explained in terms of an inhibition of class
III PI3-K, we investigated the expression of Vps34, which
is the only mammalian class III PI3-K, by immunocy-
tochemistry. As shown in Figure 5, Vps34 was indeed
expressed in the cells. It was mainly cytoplasmic, as pre-
dicted from previous reports of it being localized mainly
in the Trans-Golgi network.21 However, in a minority of
cells the labelling was restricted to the perinuclear region
(Figure 5), and, strikingly, the proportion of such cells in-
creased with serum deprivation. Counts at 16 h of culture
in 4 separate experiments showed a tenfold increase from
1.5% ±0.5% SEM to 15.0% ±3.8% SEM as a result of
serum deprivation.
Caspase-3 activation
In view of the protective effects of the pan-caspase in-
hibitor z-VAD.fmk (see above) and of a relatively spe-
cific caspase-3 inhibitor (ac-DEVD-CHO),13 we exam-
ined caspase-3 activity by immunoblotting at different
times of culture without serum and found that the pro-
tease is already activated at 12 h, and continues to be so
until at least 24 h of culture, whereas it remained inactive
in the presence of serum (Figure 6a and b). As expected,
the presence of z-VAD.fmk in the culture medium totally
inhibited caspase-3 activation, presumably by inhibiting
upstream caspases that activate caspase-3 (Figure 6a–c);
but, interestingly, the PI3-K inhibitors (LY294002 and
3-MA) enhanced both its activation and its expression
(Figure 6a–c) despite the fact that they reduced the cell
death.
Discussion
Prevention of cell death by inhibition of PI3-K
The main conclusion of this work is that the death of
serum-deprived PC12 cells, which has autophagic fea-
tures, is diminished not only by 3-MA but by the specific
PI3-kinase inhibitor LY294002 (and wortmannin in pi-
lot experiments). This same cell death had already been
shown to be inhibited by 3-MA in the same sub-line of
PC12 cells.17 Although 3-MA was introduced simply as
an inhibitor of autophagy, this action is now believed to be
due to inhibition of PI3-K2 including class III PI3-K.3
Since class III PI3-K activity is known to be necessary
for autophagy,3,24 whereas class I PI3-K activity inhibits
autophagy,3 it seemed plausible that the protective action
of 3-MA might be due to its inhibition of class III PI3-
K (which is encoded by a single gene, the mammalian
homologue of VPS34).25 However, a problem with the
extensive 3-MA data is the high concentration (10 mM)
required to protect cells, and the lack of evidence con-
cerning its specificity (apart from it being known not to
inhibit protein synthesis).26
LY294002 (and wortmannin), unlike 3-MA, have been
characterized in detail, and are known to be relatively
specific for PI3-K at concentrations of up to 50 µM
LY294002 or 100 nM wortmannin.27,28 Unfortunately,
there is little available data concerning the actions of
LY294002 and wortmannin on different classes of PI3-
K in mammalian cells, but there seems to be little
class-related specificity.29 In fission yeast the sole PI3-
K (VPS34, which has class III properties) has an IC50 to
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Figure 5. Vps34 immunocytochemistry. (a) +serum 16 h phase; (b) +serum 16 h confocal; (c) −serum 16 h phase; (d) −serum 16 h
confocal. Arrow indicates a serum-deprived cell with ring-shaped perinuclear immunostaining. Bar, 10 µm.
inhibition by LY294002 of 35 µM,30 which is higher than
for class I PI3-K in mammals but matches the LY294002
concentrations required for protection in the present
experiments.
Thus, in view of the concordant results with our 3 dif-
ferent PI3-K inhibitors (the 2 specific ones and 3-MA), it
seems reasonable to conclude that the protection mediated
by these drugs was indeed due to inhibition of PI3-K. It
is unfortunate that class-specific inhibitors are not avail-
able, and the fact that both the major PI3-K classes (I and
III) were inhibited makes it remarkable that any protec-
tion was obtained, because class I PI3-K is well known to
activate, via PDK1, the powerful protective pathway stem-
ming from Akt/PKB.31,32 This explains why PI3-K in-
hibitors generally promote cell death rather than protect-
ing against it,33 although they have been found to pro-
tect against both necrosis34 and autophagic cell death35
in a cardiomyocyte-derived cell line; surprisingly, these
exceptional cases of protection appear to have been due
to inhibition of class I PI3-K, since overexpression of
class I PI3-K enhanced cell death.34,35 Thus, in the ab-
sence of direct evidence on the class of PI3-K involved in
our present protection phenomena, interpretation is dif-
ficult; the most likely candidate is class III (mammalian
VPS34) but class I cannot be excluded.
Evidence for the causal implication of a
lysosomal pathway
The fact that specific PI3-K inhibitors diminish the
(mainly autophagic) cell death in our model is relevant
to the question of whether autophagy is really instru-
mental in “autophagic” cell death, or whether it is an
epiphenomenon (or even protective). Claims for an in-
strumental role have so far depended largely on the fact
that cell death characterized by pronounced autophagy
is in numerous situations prevented or delayed by treat-
ment with 3-MA.12,15,36–38 The confirmation of this pro-
tection with specific PI3-K inhibitors implies that it is
not due to some unknown nonspecific effect of 3-MA, but
is indeed due to inhibition of PI3-K (probably class III).
It remains possible that the key PI3-K-dependent cel-
lular event may not be autophagy itself, since class III
PI3-K plays a role in various other membrane traffick-
ing events including endosome fusion and the channeling
of lysosomal hydrolases to lysosomes.39 Thus, although
the present results do not prove that autophagy itself
is responsible for the cell death, they do indicate that
a lysosome/trafficking-related mechanism is heavily in-
volved, supporting the conclusions of Uchiyama’s group
based mainly on the prevention of this cell death by
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Figure 6. Evaluation of caspase-3 activation by immunoblotting. (a) Time course of caspase-3 activation in the presence of LY294002
or z-VAD.fmk; (b) Quantification of caspase-3 activation. Plot represents average values ±SEM from samples collected after 12 (n = 2),
16 (n = 3), 20 (n = 3) and 24 (n = 4) h treatment. Values are normalized with respect to the 24 h control (serum-deprived, no drug)
condition. (c) Effect of LY294002 or 3MA on caspase-3 expression and activation after 24 h of culture. IB, immunoblot; FL, full length.
Statistical comparisons were by one-tailed t-test. A value of p < 0.05 was considered significant: ∗LY vs. control; #LY vs z-VAD; control
vs z-VAD.
inhibition or deletion of the lysosomal protease cathepsin
D, and on its antagonism by cathepsin B.40,13 Moreover,
a death-mediating role for the autophagic pathway has
very recently been shown in two outstanding papers in
which the autophagic, non-apoptotic death of fibroblasts
was prevented by reducing the expression of autophagy
genes ATG5, ATG6 (Beclin 1) and ATG7 by means of
RNA-interference.41,42
Apoptotic and autophagic death pathways, and
their interactions
If it can be accepted that autophagy (or a closely re-
lated trafficking event) is truly instrumental in autophagic
cell death, the next question is the relation between the
autophagy-related death mechanism and the apoptotic
mechanism that was also active, and could be observed
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quite often in the very same cell. There is evidence in some
cases for shared mechanisms and cross-talk between the
apoptotic and autophagic death pathways43 but also for
a mechanism for switching between the two pathways44
that may explain why in many cases a single mechanism
predominates in a given cell.6,9,11,45–47
The present model involved both autophagic and apop-
totic features, in line with previous evidence from the
same PC12 sub-line showing autophagy and activation
of lysosomal cathepsins, but also apoptotic characteristics
including clumping of chromatin, activation of caspase-
3, moderate protection by acetyl-DEVD.cho (an inhibitor
of caspase-3-like proteinases), and strong protection by z-
VAD.fmk.13,14,17,40
The question therefore arises whether the autophagic
and apoptotic characteristics are caused by separate death
pathways acting in different cells or in parallel in the
same cell, or whether the autophagy is merely an upstream
trigger of caspase-3 activation, or a downstream effector.
Our data on the timing of the appearance of apoptotic
and autophagic features are indecisive. While a statisti-
cally significant increase in AcP-positive cells occurred
within 12 h of serum-deprivation (Figure 2b), well before
the first statistically significant increase in the number of
pyknotic cells (Figure 2c), this was paralleled by an early
activation of caspase-3 by 12 h.
In contrast, our pharmacological data do indicate that
the role of PI3-K-dependent events (such as autophagy)
in the cell death is as a separate death pathway and not
as an upstream trigger of caspase-3 activation, nor as a
downstream effector. The upstream trigger hypothesis is
contradicted by the fact that blockade of autophagy by
PI3-K inhibition, far from reducing caspase-3 activation,
strongly increased it, but nevertheless protected the cells.
The increase in caspase activation was probably caused by
inhibition of class I PI3-K, and hence of the Akt path-
way, which is strongly inhibitory to caspase-3.48 That
the autophagy was not downstream of caspase activation
(as can occur in insect development),43 was inherently
unlikely in serum-deprived PC12 cells, where lysosomal
changes occur very early (changed proteolytic activities
of cathepsins B, D and L occur within 3 h of serum-
deprivation),13 and can be ruled out by our own obser-
vation that z-VAD.fmk failed to affect the numbers of
cells with acid phosphatase-positive granules. The most
plausible alternative is that the apoptotic and autophagic
death pathways act essentially in parallel within a given
cell (or, less likely, in different cells) and with distinct
characteristics. This fits in perfectly with our observation
that z-VAD.fmk was more effective than the PI3-K in-
hibitors in reducing the numbers of pyknotic cells but
was less effective in promoting their survival measured
at 24 h; this could mean either that z-VAD.fmk switches
cells from a purely apoptotic pathway to an autophagic
death pathway involving minimum chromatin condensa-
tion, or that both pathways were often active in parallel
in the same cell and that z-VAD.fmk blocked the apop-
totic one (reducing chromatin condensation) but failed to
protect because the autophagic pathway was unaffected.
There was previous evidence that cells in which apoptosis
is blocked by a caspase-inhibitor can die by an alterna-
tive, 3-MA-dependent nonapoptotic mechanism involv-
ing autophagy but not chromatin condensation,15 and it
has recently been shown that z-VAD.fmk can even induce
autophagic cell death, again with little if any chromatin
condensation.41
In asserting that PI3-K-dependent autophagy medi-
ates autophagic cell death by a pathway separate from the
canonical, caspase-3-mediated apoptotic pathway in the
present model, we are not denying that lysosomal events
can trigger apoptosis in other situations (e.g.49,1). Even
in the present model lysosomal events may do so,17 but
by a PI3-K-independent pathway.
Conclusions
Our data indicate that autophagy, or at least a PI3-K-
mediated event related to autophagy, is instrumental in
the death of serum-deprived PC12 cells, and that the
apoptotic and autophagic features of these cells reflect
parallel death pathways, not sequential events in the same
pathway.
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